Maxwell Biosciences

SelectX Pharmaceuticals

This biopharmaceutical company develops small molecule antimicrobials and therapeutics for unmet medical needs using a genetic chemistry platform for patients with infectious diseases.

Mimetic Medicines

This company develops non-opioid peptide drug candidates for patients suffering from chronic pain.

Qpex Biopharma

This biopharmaceutical company develops novel anti-infective therapies for patients with drug-resistant bacterial infections in inpatient and outpatient settings.

MetalloBio

This company develops antimicrobial compounds and medical device coatings to combat antibiotic resistance for the pharmaceutical and healthcare sectors.

Peptilogics

This company develops engineered peptide therapeutics to treat and prevent medical device-related infections for patients undergoing joint replacements.

Omnix Medical

This biopharmaceutical company develops novel antibiotic agents for patients suffering from life-threatening, drug-resistant bacterial infections.

Amprologix

This biotechnology company develops novel antibiotics to treat antimicrobial-resistant bacterial infections for patients with conditions including MRSA and related skin and wound infections.

Infex Therapeutics

The company develops and licences antibacterial and antiviral drugs for pharmaceutical partners and healthcare providers to treat life-threatening infections and antimicrobial resistance.